chartexchange

RAIN
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock
stockNASDAQ

At CloseNov 18, 2026 2:46:12 PM EST
0.97USD-6.731%(-0.07)674,882
Pre-marketNov 18, 2026 9:29:30 AM EST
1.10USD+5.769%(+0.06)
After-hoursNov 18, 2026 4:54:30 PM EST
0.9531USD-1.742%(-0.0169)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Newark, CA, USA
Previous Close
$1.06
Beta
0.75
52-Week High
$8.52 2025-12-22
52-Week Low
$0.46 2026-11-12
SMA 50
$0.69
SMA 200
$1.70
Avg. Vol 10D
13.29M
Avg. Vol 30D
4.48M
Avg. Vol 90D
2.70M
Relative Vol
0.16
2.01M
561.8300%
679
Nov 19, 2026 (today)
RAIN Profile

rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.

RAIN Performance
PeriodPriceDateChangeBeta
1W0.512026-11-11+94.43%7.513
1M0.632026-10-19+56.75%0.693
3M0.852026-08-18+16.52%0.627
6M1.642026-05-18-39.35%0.890
1Y4.462025-11-18-77.77%0.749
2Y7.302025-01-02-86.42%—
5Y16.472021-11-18-93.98%0.682
RAIN Stock Summary

Rain Enhancement Technologies Holdco, Inc. Class A Common Stock (NASDAQ:RAIN) stock price today is $0.99, and today's volume is 702,985. RAIN is down 6.453% today. The 30 day average volume is 4.48M. RAIN market cap is $11.69M with 11.79M shares outstanding.